M3 Wake Research, Inc.

Clinical research site in Raleigh, North Carolina

Part of M3 Wake Research

As of July 2026, 2 paid clinical trials are recruiting at M3 Wake Research, Inc. in Raleigh, North Carolina. Active studies at this site cover conditions such as Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis and Metabolic Dysfunction Associated Steatohepatitis (MASH). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at M3 Wake Research, Inc. (2)

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

for Metabolic Dysfunction Associated Steatohepatitis (MASH)

163 locations incl. Birmingham

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06632444·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

for Metabolic Dysfunction Associated Steatohepatitis

125 locations incl. Peoria

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06632457·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

More research sites in Raleigh

Duke Women's Cancer Care Raleigh (15 trials)
Duke Cancer Center Raleigh (14 trials)
WakeMed (10 trials)
NC Heart and Vascular Research, LLC (6 trials)
Accellacare of Raleigh (5 trials)
NC Heart and Vascular Research (5 trials)
WakeMed Health & Hospitals (5 trials)
Duke Raleigh Hospital (4 trials)
North Carolina State University (4 trials)
UNC Health Cancer Care Raleigh (4 trials)

Explore more

Paid clinical trials in Raleigh, NC · North Carolina clinical trials